MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,510,579
Net Income
-$3,366,082
Net Profit Margin
-222.83%
EPS
-$0.64
Unit: Dollar
Revenue Breakdown
Health Care Patient Service
Histology Service Fees
Medical Director Fees
Other Revenues
Revenue Breakdown
Health Care Patient Service
Histology Service Fees
Medical Director Fees
Other Revenues
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenue
1,510,579
1,351,527
2,088,635.5*
1,446,066
Direct costs and expenses
1,087,837
928,636
1,400,166*
942,211
Research and development
361,575
349,707
420,417.5*
330,589
Clinical development
475,885
334,040
296,859*
143,311
Selling, general and administrative
2,858,590
3,241,602
2,447,333.5*
2,209,441
Depreciation and amortization
61,556
114,518
164,952.5*
113,360
Total operating expenses
4,845,443
4,968,503
4,729,728.5*
3,738,912
Loss from operations
-3,334,864
-3,616,976
-2,641,093*
-2,292,846
Interest income
3,358
10,026
18,715.5*
1,088
Interest expense
11,688
14,722
20,645*
5,358
Other income
4,738
-
-17,359*
513
Other expense
27,626
8,938
490,912*
3,839
Change in fair value of warrants issued
-
-
-1,905,139*
2,747,460
Total other income (expense), net
-31,218
-13,634
-
-2,755,056
Net loss before provision for income tax expense
-3,366,082
-3,630,610
-1,246,154.5*
-5,047,902
Income tax expense
-
-
-4,207*
3,182
Net loss
-3,366,082
-3,630,610
-1,241,947.5
-5,051,084
Basic EPS
-0.64
-0.81
-0.722
-4.74
Diluted EPS
-0.64
-0.81
-0.722
-4.74
Basic Average Shares
5,226,753
4,494,752
1,721,082*
1,066,350
Diluted Average Shares
5,226,753
4,494,752
1,721,082*
1,066,350
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
-$3,366,082
(17.11%↑ Y/Y)
Health Care Patient
Service
$1,244,142
Histology Service Fees
$248,260
Medical Director Fees
$17,544
Other Revenues
$633
Net loss before
provision for income tax...
-$3,366,082
(16.51%↑ Y/Y)
Laboratory Services
$1,510,579
Loss from operations
-$3,334,864
(-32.57%↓ Y/Y)
Total other income
(expense), net
-$31,218
(97.94%↑ Y/Y)
Net revenue
$1,510,579
(18.99%↑ Y/Y)
Other income
$4,738
(-87.55%↓ Y/Y)
Interest income
$3,358
(65.83%↑ Y/Y)
Total operating
expenses
$4,845,443
(28.02%↑ Y/Y)
Other expense
$27,626
(-94.28%↓ Y/Y)
Interest expense
$11,688
(11.74%↑ Y/Y)
Selling, general and
administrative
$2,858,590
(29.08%↑ Y/Y)
Direct costs and
expenses
$1,087,837
(7.01%↑ Y/Y)
Clinical development
$475,885
(268.11%↑ Y/Y)
Research and development
$361,575
(16.12%↑ Y/Y)
Depreciation and
amortization
$61,556
(-45.64%↓ Y/Y)
Buy us a coffee
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF)